Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among Chinese Han women

PLoS One. 2013 Dec 27;8(12):e84489. doi: 10.1371/journal.pone.0084489. eCollection 2013.

Abstract

The CCNB1 and CDK1 genes encode the proteins of CyclinB1 and CDK1 respectively, which interact with each other and are involved in cell cycle regulation, centrosome duplication and chromosome segregation. This study aimed to investigate whether the genetic variants in these two genes may affect breast cancer (BC) susceptibility, progression, and survival in Chinese Han population using haplotype-based analysis. A total of ten tSNPs spanning from 2kb upstream to 2kb downstream of these genes were genotyped in 1204 cases and 1204 age-matched cancer-free controls. The haplotype blocks were determined according to our genotyping data and linkage disequilibrium (LD) status of these SNPs. For CCNB1, rs2069429 was significantly associated with increased BC susceptibility under recessive model (OR=2.352, 95%CI=1.480-3.737), so was the diplotype TAGT/TAGT (OR=1.947 95%CI=1.154-3.284, P=0.013). In addition, rs164390 was associated with Her2-negative BC. For CDK1, rs2448343 and rs1871446 were significantly associated with decreased BC risk under dominant models, so was the haplotype ATATT. These two SNPs also showed a dose-dependent effect on BC susceptibility. Using stratified association analysis, we found that women with the heterozygotes or minor allele homozygotes of rs2448343 had much less BC susceptibility among women with BMI<23. In CDK1, three closely located SNPs, rs2448343, rs3213048 and rs3213067, were significantly associated with tumor's PR status: the heterozygotes of rs2448343 were associated with PR-positive tumors, while the minor allele homozygotes of rs3213048 and heterozygotes of rs3213067 were associated with PR-negative BC tumors. In survival analysis, rs1871446 was associated with unfavorable event-free survival under recessive model, so was the CDK1 diplotype ATATG/ATATG, which carried the minor allele homozygote of rs1871446. Our study indicates that genetic polymorphisms of CCNB1 and CDK1 are related to BC susceptibility, progression, and survival in Chinese Han women. Further studies need to be performed in other populations as an independent replication to verify these results.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / mortality*
  • CDC2 Protein Kinase
  • China / epidemiology
  • Cyclin B1 / genetics*
  • Cyclin-Dependent Kinases / genetics*
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Polymorphism, Single Nucleotide*
  • Retrospective Studies
  • Survival Rate

Substances

  • CCNB1 protein, human
  • Cyclin B1
  • CDC2 Protein Kinase
  • CDK1 protein, human
  • Cyclin-Dependent Kinases

Grants and funding

This study was supported by the National Natural Science Foundation of China (No 81171961) and Doctoral Fund of Ministry of Education of China (No 20110001110060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.